Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Associated Study" patented technology

An indication that one study is related to another. (NCI)

Cervinae activin A protein and preparation method and application thereof

The invention relates to the field of molecular biology and particularly relates to a cervinae activin A protein and a preparation method and application thereof. The activin A protein is composed oftwo cervinae activin beta A subunits isolated from cervinae animals. The study on the activin A protein is still relatively rare in the cervinae. The preparation method acquires the isolated gene sequence, improves its high-purity protein expression method, provides research basis and novel ideas for related research and greatly increases the research and application prospect of the activin A protein.
Owner:INST OF SPECIAL ANIMAL & PLANT SCI OF CAAS

Method for verifying reason for promoting HCC chemotherapy drug resistance by regulating PTEN-AKT signal axis through UBE2S

The invention provides a method for verifying reasons for promoting HCC chemotherapy drug resistance by using UBE2S to regulate a PTEN-AKT signal axis. The method comprises the following processes: verifying a relationship between UBE2S in HCC and a drug-resistant pathway, silencing UBE2S in HCC cells, and verifying UBE2S and the drug-resistant pathway by using an RNA-seq technology and gene enrichment analysis; the drug resistance of UBE2S expression in the HCC cells to fluorouracil and oxaliplatin is verified; the correlation between the transcription factor FOXM1 and UBE2S expression is verified; fOXM1-UBE2S downstream molecules and the regulation and control effect thereof, in-vivo experiments and in-vitro experiments are verified. The invention verifies that abnormal high expression of UBE2S exists in chemotherapy-resistant HCC cells, and influences on chemotherapy resistance by promoting PTEN ubiquitination, reducing the PTEN protein expression level and regulating and controlling a PI3K-AKT signal axis are achieved. UBE2S is taken as an HCC chemotherapy curative effect prediction index, the potential of a new drug-resistant target is reversed, and related researchers are facilitated to improve the curative effect and improve the prognosis of patients by overcoming HCC chemotherapy drug resistance.
Owner:桂亮

Preparation method and application of hawthorn EST-SSR (Expression Sequence Tag-Simple Sequence Repeats) marker primer

InactiveCN108330207APromote and improve the level of basic researchMicrobiological testing/measurementDNA/RNA fragmentationAgricultural scienceBasic research
The invention discloses a preparation method of a hawthorn EST-SSR (Expression Sequence Tag-Simple Sequence Repeats) marker primer. The preparation method comprises the following steps: 1) screening and assembling segment sequences with the length greater than 5000bp from hawthorn transcriptome data; 2) carrying out SSR digging on each segment by utilizing SSR Hunter software; picking out EST sequences which contain rich dinucleotide, trinucleotide, tetranucleotide or pentanucleotide repeats and has the length greater than or equal to 10bp from a single sequence; 3) screening an EST-SSR primeron 150bp base sequences at upstream and downstream of SSR by utilizing primer 3 software, so as to obtain the hawthorn EST-SSR marker primer. The invention provides the preparation method and application of the hawthorn EST-SSR marker primer, reference is provided for related researches of hawthorns in the future and a basic research level of the hawthorns is promoted and improved.
Owner:SHENYANG AGRI UNIV

Construction method of gene overexpression chimeric animal model based on hNPY and application of construction method

The invention discloses a construction method of a gene overexpression chimeric animal model based on hNPY and application of the construction method. The method comprises the following steps: takingconstructed Synapsin as a promoter to drive an hNPY lentiviral expression vector; injecting the vector into the paraventricular nucleus of macaque; and transcribing hNPY into paraventricular nucleus cell gene to realize overexpression of hNPY gene, and inducing phenotype generation to form the gene overexpression chimeric animal model based on the hNPY. The method can be used for pathogenesis research of related diseases, screening, verification and testing of therapeutic drugs researched by clinical treatment means, pre-clinical related research and the like. The method has the characteristics of short animal model construction period, high efficiency, low cost, high phenotypic explicit rate, good synchronism, high repeatability, low difficulty, convenience in large-scale application andthe like.
Owner:四川横竖生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products